pocketful logo light
pocketful logo light
Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd

NSE: BLISSGVS BSE: 506197

₹579.10

(0.18%)

Tue, 25 Aug 2026, 11:05 am

mtf coin illustrationMTF 5x

Bliss GVS Pharma Share Price Live Chart

1 Day

(0.18%)

No Result Found

Summary

  • Market Cap (in Cr)

    4493.92

  • Net Profit (in Cr)

    90.26

  • P/B

    1.18

  • Sector P/E

    33.76

  • P/E

    14.69

  • EV/EBITDA

    6.82

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    8.95

  • ROCE

    12.09

  • Debt/Equity

    0.09

  • EPS (TTM)

    12.36

  • Dividend Yield

    0.24

  • Book Value

    112.76

  • Interest Cover

    16.47

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters35.3635.3635.3935.4435.29
FII10.4514.5413.2712.6513.18
DII5.045.785.986.546.55
Public49.1544.3245.3645.3644.98
Government00000

Read More

Technical Analysis

RSI

67.18

MACD

25.04

50 DMA

499.76

200 DMA

293.74

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic694.15589.75527.70485.35423.30380.95276.55
Fibonacci589.75549.87525.23485.35445.47420.83380.95
Camarilla494.36484.79475.22485.35456.08446.51436.94

Pivots Level: Classic

R3

+208.80

694.15

R2

+104.40

589.75

R1

+42.35

527.70

485.35
485.35
Pivot Point
LTP: 561.50

S1

-62.05

423.30

S2

-104.40

380.95

S3

-208.80

276.55

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    547.24

  • 20-EMA

    525.39

  • 30-EMA

    511.36

  • 50-EMA

    484.85

  • 100-EMA

    421.09

  • 200-EMA

    337.74

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 May 2026board-meetingsAccounts, Final Dividend
12 May 2026agm
10 Feb 2026board-meetingsQuarterly Results, Interim Dividend
10 Feb 2026dividend₹0.50 Dividend /Share18 Feb 2026
18 Jan 2026dividendInterim Dividend - Re 0.50 Per Share18 Feb 2026
06 Nov 2025board-meetingsQuarterly Results
24 Jun 2025dividendFinal Dividend - Rs. - 0.524 Jul 2025
12 May 2025dividend₹0.50 Dividend /Share24 Jul 2025
12 May 2025agm
18 Jun 2024dividendAnnual General Meeting/Dividend - Rs 0.50 Per Share19 Jul 2024

Read More

Peer Comparison

Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Bliss GVS Pharma Ltd About

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1984

Headquarters

CEO

Nandkumar Kashinath Chodankar

Employees

Contact

Website icon

Website

http://www.blissgvs.com

Email icon

Email

cs@blissgvs.com; info@blissgvs.com

Phone icon

Phone

91-22-42160000

Location icon

Location

102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072

Read More

Bliss GVS Pharma Ltd Company History

YearHistory
2012
  • Company has acquired 70% management stake in the Company M/s. Kremoint Pharma Private Limited
2013
  • Bliss GVS Pharma Ltd recommended a dividend of 40%
  • Bliss GVS receives recognition for its Research & Development Lab from the Department of Scientific & Industrial Research (DSIR), Government of India.
2014
  • Bliss GVS is named in Moneylife magazine's 'Wealth Creators 2004-2013' list
  • Bliss GVS Wins - Outstanding Exports Award.
2015
  • Bliss GVS Pharma wins Healthcare Services contract in Kenya
2016
  • Bliss GVS Pharma arm wins $111 mn contract from Kenyan firm.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDbulkBuy457998419.2629 May 2026
HRTI PRIVATE LIMITEDbulkSell562933420.4929 May 2026
SHAILESH SHIVKUMAR DALMIAbulkSell1008910317.6425 May 2026
HRTI PRIVATE LIMITEDbulkBuy517506224.2625 Mar 2026
HRTI PRIVATE LIMITEDbulkSell581292224.8625 Mar 2026
RATNABALI EQUITY PRIVATE LIMITEDbulkBuy717000212.5620 Mar 2026
RATNABALI EQUITY PRIVATE LIMITEDbulkSell717102212.1120 Mar 2026
ARIAN INVESTMENT LTDbulkSell1000000210.8219 Mar 2026
MATEUS LTDbulkBuy933978210.8119 Mar 2026
MANSUKH SECURITIES & FINANCE LIMITEDbulkBuy620900220.8124 Feb 2026

Read More

Bliss GVS Pharma Ltd News

Bliss GVS Pharma accepts Sachin Saboo's resignation

Bliss GVS Pharma Limited has accepted the resignation of Sachin Saboo, General Manager – Regulatory & Clinical, effective July 24, 2026. He cited professional aspirations as the reason for his departure.

25 Jul 2026

companies

Anupam Rasayan adds Mates Visa as PAC

Anupam Rasayan India Ltd designated Mates Visa Consultancy Pvt Ltd as a person acting in concert for its open offer to acquire 26% of Bliss GVS Pharma Ltd.

19 Jul 2026

companies

Bliss GVS Pharma declares final dividend

Bliss GVS Pharma declared a final dividend of Re. 1.00 per share for FY26 at its 41st AGM. Shareholders approved financial statements and director re-appointment.

15 Jul 2026

companies

Bliss GVS Pharma appoints new CEO and director

Bliss GVS Pharma appointed Rahul Adakmol as CEO effective July 15, 2026, and Santosh Parab as Additional Director. Narsimha Kamath stepped down as CEO.

03 Jul 2026

companies

Bliss GVS Pharma Posts Strong FY26 Results

Bliss GVS Pharma reports consolidated revenue of ₹1,00,064.26 Lakh in FY26, up 18.26% YoY, with consolidated net profit rising 49.27% to ₹13,472.77 Lakh. Final dividend of ₹1.00 per share recommended.

23 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number